|
Zinc dysregulation as a druggable target in human skin photocarcinogenesis
|
1R03CA230949-01
|
$73,677
|
WONDRAK, GEORG
|
UNIVERSITY OF ARIZONA
|
|
Xenobiotic metabolism, cancer chemoprevention and cancer biomarkers
|
ZIA BC 005708
|
$531,469
|
Gonzalez, Frank
|
CCR (NCI)
|
|
Weill Cornell Medicine (WCM) SPORE in Prostate Cancer
|
5P50CA211024-02
|
$2,283,108
|
RUBIN, MARK
|
WEILL MEDICAL COLL OF CORNELL UNIV
|
|
Weight cycling and total and site-specific cancer incidence and mortality
|
5R03CA204825-02
|
$79,500
|
GIOVANNUCCI, EDWARD
|
HARVARD SCHOOL OF PUBLIC HEALTH
|
|
Water Soluble Polymers to Target Tumor-Associated Extracellular Matrix for Delivery of MMP Inhibitors
|
5F31CA213901-02
|
$44,524
|
SUBRAHMANYAM, NITHYA
|
UNIVERSITY OF UTAH
|
|
Vesicular Stomatitis Virus (VSV) Replication in Malignant Cells
|
5R01CA194404-04
|
$334,911
|
BARBER, GLEN
|
UNIVERSITY OF MIAMI SCHOOL OF MEDICINE
|
|
Vermont Breast Cancer Molecular Characterization Laboratory
|
5U01CA196383-04
|
$312,000
|
STEIN, JANET
|
UNIVERSITY OF VERMONT & ST AGRIC COLLEGE
|
|
VDAC Regulation of Warburg Metabolism in Hepatocarcinoma
|
5R01CA184456-03
|
$341,981
|
MALDONADO, EDUARDO
|
MEDICAL UNIVERSITY OF SOUTH CAROLINA
|
|
Vascular Biology Section
|
ZIA BC 011390
|
$1,186,781
|
Lin, Pengnian Charles
|
CCR (NCI)
|
|
Vanderbilt Training Program in Molecular and Genetic Epidemiology of Cancer
|
5T32CA160056-08
|
$435,520
|
SHU, XIAO-OU
|
VANDERBILT UNIVERSITY MEDICAL CENTER
|
|
Validation of Novel Therapeutic Approach for Leptomeningeal Metastases
|
2R42CA206744-02A1
|
$665,919
|
MCCABE, AARON
|
MINNETRONIX, INC.
|
|
Validation of circulating tumor DNA assays for detection of metastatic melanoma
|
4UH3CA206124-03
|
$423,750
|
POLSKY, DAVID
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
|
Vaccine and radiation for the therapy of human cancers
|
ZIA BC 010975
|
$532,008
|
Hodge, James
|
CCR (NCI)
|
|
Vaccine and Drug Combination Therapy for Human Cancers
|
ZIA BC 010661
|
$532,008
|
Hodge, James
|
CCR (NCI)
|
|
UW Comprehensive Cancer Center Support
|
3P30CA014520-35S1
|
$59,955
|
WILDING, GEORGE
|
UNIVERSITY OF WISCONSIN MADISON
|
|
UW Comprehensive Cancer Center Support
|
5P30CA014520-35
|
$4,795,480
|
WILDING, GEORGE
|
UNIVERSITY OF WISCONSIN MADISON
|
|
Utilizing Precision Medicine to elucidate the mechanisms underpinning treatment efficacy
|
1K99CA230384-01
|
$107,860
|
HOPKINS, BENJAMIN
|
WEILL MEDICAL COLL OF CORNELL UNIV
|
|
Utilizing Nucleic-Acid Scavengers to Ameliorate Inflammation-driven Metastatic Progression in Breast Cancer
|
1F31CA232394-01
|
$35,885
|
ETESHOLA, ELIAS
|
DUKE UNIVERSITY
|
|
Using Zebrafish to Identify and Analyze Cancer Genes
|
5R01CA106416-03
|
$398,901
|
Lees, Jacqueline
|
MASSACHUSETTS INSTITUTE OF TECHNOLOGY
|
|
Using SMART Design to Improve Symptom Management Strategies Among Cancer Patients
|
5R01CA193706-03
|
$554,574
|
WYATT, GWEN
|
MICHIGAN STATE UNIVERSITY
|
|
Using patient-derived models to understand drug responses in SCLC
|
1U01CA220323-01A1
|
$619,923
|
DYSON, NICHOLAS
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
Using hunger training to enhance weight loss and modulate cancer-related biomarkers in women at high risk for breast cancer: a pilot study
|
5R21CA215415-02
|
$174,000
|
BASEN-ENGQUIST, KAREN
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
Using Diazeniumdiolate Chemistry to Design Nitric Oxide-Based Therapies
|
Z01 BC 005673
|
$1,225,024
|
Keefer, Larry
|
CCR (NCI)
|
|
Using Community-Engaged Methods to Design a Tool to Promote Informed Breast Cancer Screening Decisions for Low Literacy Women
|
1K07CA221899-01A1
|
$129,704
|
GUNN, CHRISTINE
|
BOSTON MEDICAL CENTER
|
|
University of Texas PDX Development and Trial Center
|
3U54CA224065-01S1
|
$175,000
|
ROTH, JACK
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
University of California Minority Patient-Derived Xenograft (PDX) Development and Trial Center (UCaMP) to Reduce Cancer Health Disparities
|
1U54CA233306-01
|
$6,160,778
|
PAN, CHONG-XIAN
|
UNIVERSITY OF CALIFORNIA AT DAVIS
|
|
Uniting Mass Spectrometry and Glycoscience to Investigate Cancer Biology
|
4K00CA212454-03
|
$71,550
|
RILEY, NICHOLAS
|
STANFORD UNIVERSITY
|
|
Understanding Wnt5a regulation of protein depalmitoylation during cell migration
|
3R01CA181633-05S1
|
$69,420
|
WITZE, ERIC
|
UNIVERSITY OF PENNSYLVANIA
|
|
Understanding Treatment Tolerability in Older Patients with Cancer
|
1U01CA233167-01
|
$649,295
|
MOHILE, SUPRIYA
|
UNIVERSITY OF ROCHESTER
|
|
Understanding the mechanisms of immune suppression in lymph node metastases
|
1K22CA230315-01
|
$200,880
|
JONES, DENNIS
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
|
Understanding the AGL metastasis suppressor for therapeutic gain
|
3R01CA143971-08S1
|
$149,644
|
THEODORESCU, DAN
|
CEDARS-SINAI MEDICAL CENTER
|
|
Understanding the AGL metastasis suppressor for therapeutic gain
|
7R01CA143971-08
|
$481,438
|
THEODORESCU, DAN
|
CEDARS-SINAI MEDICAL CENTER
|
|
Understanding sex differences in colon cancer metabolism
|
1R21CA223686-01A1
|
$182,156
|
JOHNSON, CAROLINE
|
YALE UNIVERSITY
|
|
Understanding Psychosocial and Immunologic Responses in Indolent Lymphoproliferative Disorders
|
5R01CA194263-03
|
$632,188
|
FANG, CAROLYN
|
RESEARCH INST OF FOX CHASE CAN CTR
|
|
Understanding metabolic vulnerabilities in cancer and the impact the tumor microenvironment has on cancer progression.
|
1F99CA234942-01
|
$36,295
|
RUSSELL, SHONAGH
|
UNIVERSITY OF SOUTH FLORIDA
|
|
Understanding Ikaros molecular functions for targeted therapies of pre-B ALL
|
1R01CA230618-01
|
$373,355
|
SCHJERVEN, HILDE
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Understanding barriers to single-dose intravesical chemotherapy in non-muscle invasive bladder cancer
|
5K23CA212272-03
|
$144,313
|
CARY, KELLY
|
INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
|
|
Understanding and Predicting Fatigue, CV Decline & Events After Breast CA Treatment
|
5R01CA199167-03
|
$635,180
|
HUNDLEY, WILLIAM
|
WAKE FOREST UNIVERSITY HEALTH SCIENCES
|
|
Understanding and Addressing Cancer Health Disparities in Louisiana
|
1P20CA233374-01
|
$976,081
|
OCHOA, AUGUSTO
|
LSU HEALTH SCIENCES CENTER
|
|
Uncovering Mechanisms of Regulation and Dependency on Fatty Acid Oxidation in MYC-Driven Tumors
|
1R01CA223817-01A1
|
$366,000
|
GOGA, ANDREI
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Uncovering Gene Expression Differences between Benign and Premalignant Colorectal Polyps
|
5R21CA208461-02
|
$175,237
|
VILAR-SANCHEZ, EDUARDO
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
Ultrasound-based diagnostic and monitoring of bladder cancer treatment with drug released from nanoparticles
|
1R43CA232778-01
|
$295,240
|
ASSOULINE, JOE
|
NANOMEDTRIX, LLC
|
|
Ultrasound Tomography
|
ZIA CP010126 10555
|
$25,880
|
Benson, Gretchen
|
DCEG (NCI)
|
|
Ultra-High Content Analysis (UHCA) of Single Cells in Tissue: 60+ channel immunofluorescence labeling kits and companion imaging software for everyone
|
4R44CA224994-02
|
$749,974
|
NEDERLOF, MICHEL
|
QUANTITATIVE IMAGING SYSTEMS, LLC
|
|
UGI cancer studies - other
|
ZIA CP000185 10319
|
$68,165
|
Dawsey, Sandy
|
DCEG (NCI)
|
|
Uganda-UCSF Consortium on Prevention and Early Detection of HIV-Associated Cancer
|
5U54CA190153-05
|
$561,777
|
MARTIN, JEFFREY
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
UCSC-Buck Specialized Genomic Data Analysis Center for the Genomic Data Analysis Network
|
5U24CA210990-03
|
$449,240
|
STUART, JOSHUA
|
UNIVERSITY OF CALIFORNIA SANTA CRUZ
|
|
Ubiquilin1 regulates EMT and metastasis of human lung adenocarcinoma
|
3R01CA193220-04S2
|
$39,768
|
BEVERLY, LEVI
|
UNIVERSITY OF LOUISVILLE
|
|
U.T. M. D. Anderson Cancer Center SPORE in Ovarian Cancer
|
5P50CA217685-02
|
$1,813,624
|
BAST, ROBERT
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
U.S. Hyperthyroidism study
|
ZIA CP010131 04175
|
$374,517
|
Kitahara, Cari
|
DCEG (NCI)
|
Relevant funding data is only available when one cancer type or one research topic is selected.
|